HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Thiemermann Selected Research

Thiopental (Pentothal)

7/2004Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia.
12/2002Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.
7/2002Ligands of the peroxisome proliferator-activated receptor-PPAR-a reduce myocardial infarct size.
1/2002Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Thiemermann Research Topics

Disease

67Inflammation (Inflammations)
01/2022 - 03/2000
51Ischemia
03/2021 - 03/2002
47Shock
01/2022 - 01/2002
47Reperfusion Injury
01/2019 - 01/2002
43Sepsis (Septicemia)
01/2022 - 11/2003
23Endotoxemia
01/2020 - 03/2000
20Necrosis
08/2010 - 01/2002
19Multiple Organ Failure (MODS)
07/2022 - 01/2002
18Hemorrhagic Shock
07/2022 - 09/2002
17Wounds and Injuries (Trauma)
07/2022 - 08/2003
15Septic Shock (Toxic Shock Syndrome)
05/2016 - 07/2002
12Infarction (Infarctions)
10/2013 - 07/2002
11Acute Kidney Injury (Acute Renal Failure)
01/2018 - 07/2002
11Myocardial Infarction
01/2018 - 07/2002
10Hemorrhage
07/2022 - 05/2002
10Hypotension (Low Blood Pressure)
01/2022 - 04/2003
9Body Weight (Weight, Body)
09/2020 - 10/2002
9Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 07/2002
9Hypoxia (Hypoxemia)
03/2013 - 08/2003
7Obesity
01/2022 - 01/2013
7Critical Illness (Critically Ill)
02/2021 - 05/2006
7Infections
01/2020 - 09/2002
7Lung Injury
01/2018 - 01/2002
7Colitis
01/2007 - 02/2003
6Pleurisy (Pleuritis)
01/2015 - 01/2002
6Edema (Dropsy)
08/2008 - 05/2002
5Insulin Resistance
01/2021 - 08/2010
5Pneumonia (Pneumonitis)
01/2018 - 12/2010
5Arthritis (Polyarthritis)
10/2013 - 10/2002
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2013 - 02/2003
5Experimental Arthritis
07/2006 - 01/2002
4Cardiomyopathies (Cardiomyopathy)
01/2022 - 11/2016
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2005
4Chronic Kidney Failure (Chronic Renal Failure)
09/2020 - 11/2003
4Fibrosis (Cirrhosis)
09/2020 - 07/2017

Drug/Important Bio-Agent (IBA)

25LigandsIBA
01/2018 - 07/2002
23CytokinesIBA
01/2022 - 03/2000
21PPAR gammaIBA
08/2010 - 05/2002
19ErythropoietinFDA Link
09/2013 - 07/2004
18Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2021 - 03/2000
18CreatinineIBA
09/2020 - 12/2002
16Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 03/2000
16EnzymesIBA
01/2022 - 01/2002
16LipopolysaccharidesIBA
01/2020 - 04/2003
15Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 07/2002
14Peroxidase (Myeloperoxidase)IBA
01/2022 - 02/2003
14Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2007 - 12/2002
13Alanine Transaminase (SGPT)IBA
01/2018 - 03/2004
13NF-kappa B (NF-kB)IBA
06/2015 - 01/2002
12Glycogen Synthase (Synthase I)IBA
09/2011 - 03/2006
11EndotoxinsIBA
01/2022 - 01/2002
10Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2002
10Insulin (Novolin)FDA Link
01/2021 - 03/2005
10Reactive Oxygen Species (Oxygen Radicals)IBA
09/2008 - 01/2002
9Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2022 - 01/2002
9Peptidoglycan (Murein)IBA
01/2020 - 07/2002
8InflammasomesIBA
01/2022 - 01/2013
8Urea (Carbamide)FDA LinkGeneric
09/2020 - 12/2002
8(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
01/2018 - 02/2010
8Transcription Factors (Transcription Factor)IBA
07/2017 - 01/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 03/2000
8DNA (Deoxyribonucleic Acid)IBA
03/2013 - 01/2002
8PPAR-gamma AgonistsIBA
08/2010 - 08/2003
83-nitrotyrosineIBA
05/2010 - 05/2002
8ZymosanIBA
02/2010 - 01/2002
84- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
01/2009 - 03/2006
8Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2008 - 01/2002
7Phosphotransferases (Kinase)IBA
01/2021 - 03/2012
7Glycogen Synthase Kinase 3 betaIBA
09/2008 - 09/2005
7Lipase (Acid Lipase)FDA Link
10/2005 - 05/2002
75-aminoisoquinolinoneIBA
05/2005 - 01/2002
7Rosiglitazone (Avandia)FDA Link
03/2005 - 07/2002
6Pharmaceutical PreparationsIBA
01/2022 - 10/2007
6salicylhydroxamic acid (SHAM)IBA
01/2020 - 02/2007
6Caspase 3 (Caspase-3)IBA
12/2018 - 08/2003
6CarrageenanIBA
01/2015 - 01/2002
6Superoxide DismutaseIBA
09/2008 - 01/2002
6Interleukin-1beta (Interleukin 1 beta)IBA
02/2008 - 03/2000
6Malondialdehyde (Propanedial)IBA
03/2005 - 11/2002
5LipidsIBA
03/2021 - 01/2007
5Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
12/2013 - 05/2003
5Glycogen Synthase KinasesIBA
05/2012 - 01/2007
5PPAR alphaIBA
08/2010 - 07/2002
5Interleukin-6 (Interleukin 6)IBA
08/2010 - 06/2002
5Hydrogen Sulfide (Sulfide, Hydrogen)IBA
02/2010 - 10/2005
5BilirubinIBA
11/2009 - 03/2004
5SodiumIBA
03/2009 - 07/2002
5Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2008 - 01/2002
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2008 - 05/2005
5HDL LipoproteinsIBA
01/2007 - 07/2003
5Creatine Kinase (Creatine Phosphokinase)IBA
01/2007 - 03/2004
5DinitrobenzenesIBA
01/2005 - 02/2003
4Agammaglobulinaemia Tyrosine KinaseIBA
12/2021 - 01/2019
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 06/2007
4AdenineFDA LinkGeneric
09/2020 - 03/2014

Therapy/Procedure

34Therapeutics
01/2020 - 01/2002
21Resuscitation
07/2022 - 09/2002
14Ligation
01/2022 - 08/2003
13Punctures
01/2022 - 02/2006
7Critical Care (Surgical Intensive Care)
10/2018 - 09/2004